Loading…
Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography
Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit...
Saved in:
Published in: | Biotechnology journal 2007-01, Vol.2 (1), p.68-75 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3 |
container_end_page | 75 |
container_issue | 1 |
container_start_page | 68 |
container_title | Biotechnology journal |
container_volume | 2 |
creator | Guiffant, Damien Tribouillard, Déborah Gug, Fabienne Galons, Hervé Meijer, Laurent Blondel, Marc Bach, Stéphane |
description | Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects. |
doi_str_mv | 10.1002/biot.200600223 |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00169462v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19772194</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxSMEoqVw5YhyQuKQxXbir2OpaHel7cdhEUdr4ji7BidebKdl_3sSslq49TQez-89jeZl2XuMFhgh8rm2Pi0IQmxsSPkiO8eCoYKXuHp5fDPOxFn2JsYfCFW0RNXr7AxzQiih-DwLq8b0ybZWQ7K-z32b2z4F0Ma5wUHIE4StSXEaxA6cyzvvjP47ejJ2u0u53plulLtc-27vh76J-RBtv82hbW1v02Ekgu8g-W2A_e7wNnvVgovm3bFeZN-uv26ulsX6_mZ1dbkudMV4WQgsodQUBNW85pw1iHKCpWSNJqLGQBpppK65FIAxM9DUlGgqQLCWNRVtyovs0-y7A6f2wXYQDsqDVcvLtZr-EMJMVow84pH9OLP74H8NJibV2TjdAHrjh6iYkBUm1fMglnzashrBxQzq4GMMpj2tgJGaolNTdOoU3Sj4cHQe6s40__BjViMgZ-DJOnN4xk59Wd1v_jcvZq2Nyfw-aSH8VOOtOVXf727UQymW_PaWqk35B52StlY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19772194</pqid></control><display><type>article</type><title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Guiffant, Damien ; Tribouillard, Déborah ; Gug, Fabienne ; Galons, Hervé ; Meijer, Laurent ; Blondel, Marc ; Bach, Stéphane</creator><creatorcontrib>Guiffant, Damien ; Tribouillard, Déborah ; Gug, Fabienne ; Galons, Hervé ; Meijer, Laurent ; Blondel, Marc ; Bach, Stéphane</creatorcontrib><description>Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.</description><identifier>ISSN: 1860-6768</identifier><identifier>EISSN: 1860-7314</identifier><identifier>DOI: 10.1002/biot.200600223</identifier><identifier>PMID: 17225251</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Affinity chromatography ; Biochemistry, Molecular Biology ; Biopolymers ; Biopolymers - analysis ; Biopolymers - chemistry ; Chromatography, Affinity ; Chromatography, Affinity - methods ; Competition assays ; Drug Design ; Life Sciences ; Microchemistry ; Microchemistry - methods ; Molecular Weight ; Pharmaceutical Preparations ; Pharmaceutical Preparations - chemistry ; Selectivity ; Subcellular Fractions ; Subcellular Fractions - chemistry</subject><ispartof>Biotechnology journal, 2007-01, Vol.2 (1), p.68-75</ispartof><rights>Copyright © 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</citedby><cites>FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</cites><orcidid>0000-0002-7186-7483 ; 0000-0003-3511-4916 ; 0000-0003-4897-2995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17225251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00169462$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Guiffant, Damien</creatorcontrib><creatorcontrib>Tribouillard, Déborah</creatorcontrib><creatorcontrib>Gug, Fabienne</creatorcontrib><creatorcontrib>Galons, Hervé</creatorcontrib><creatorcontrib>Meijer, Laurent</creatorcontrib><creatorcontrib>Blondel, Marc</creatorcontrib><creatorcontrib>Bach, Stéphane</creatorcontrib><title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</title><title>Biotechnology journal</title><addtitle>Biotechnology Journal</addtitle><description>Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.</description><subject>Affinity chromatography</subject><subject>Biochemistry, Molecular Biology</subject><subject>Biopolymers</subject><subject>Biopolymers - analysis</subject><subject>Biopolymers - chemistry</subject><subject>Chromatography, Affinity</subject><subject>Chromatography, Affinity - methods</subject><subject>Competition assays</subject><subject>Drug Design</subject><subject>Life Sciences</subject><subject>Microchemistry</subject><subject>Microchemistry - methods</subject><subject>Molecular Weight</subject><subject>Pharmaceutical Preparations</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Selectivity</subject><subject>Subcellular Fractions</subject><subject>Subcellular Fractions - chemistry</subject><issn>1860-6768</issn><issn>1860-7314</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkc1v1DAQxSMEoqVw5YhyQuKQxXbir2OpaHel7cdhEUdr4ji7BidebKdl_3sSslq49TQez-89jeZl2XuMFhgh8rm2Pi0IQmxsSPkiO8eCoYKXuHp5fDPOxFn2JsYfCFW0RNXr7AxzQiih-DwLq8b0ybZWQ7K-z32b2z4F0Ma5wUHIE4StSXEaxA6cyzvvjP47ejJ2u0u53plulLtc-27vh76J-RBtv82hbW1v02Ekgu8g-W2A_e7wNnvVgovm3bFeZN-uv26ulsX6_mZ1dbkudMV4WQgsodQUBNW85pw1iHKCpWSNJqLGQBpppK65FIAxM9DUlGgqQLCWNRVtyovs0-y7A6f2wXYQDsqDVcvLtZr-EMJMVow84pH9OLP74H8NJibV2TjdAHrjh6iYkBUm1fMglnzashrBxQzq4GMMpj2tgJGaolNTdOoU3Sj4cHQe6s40__BjViMgZ-DJOnN4xk59Wd1v_jcvZq2Nyfw-aSH8VOOtOVXf727UQymW_PaWqk35B52StlY</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Guiffant, Damien</creator><creator>Tribouillard, Déborah</creator><creator>Gug, Fabienne</creator><creator>Galons, Hervé</creator><creator>Meijer, Laurent</creator><creator>Blondel, Marc</creator><creator>Bach, Stéphane</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley-VCH Verlag</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-7186-7483</orcidid><orcidid>https://orcid.org/0000-0003-3511-4916</orcidid><orcidid>https://orcid.org/0000-0003-4897-2995</orcidid></search><sort><creationdate>200701</creationdate><title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</title><author>Guiffant, Damien ; Tribouillard, Déborah ; Gug, Fabienne ; Galons, Hervé ; Meijer, Laurent ; Blondel, Marc ; Bach, Stéphane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Affinity chromatography</topic><topic>Biochemistry, Molecular Biology</topic><topic>Biopolymers</topic><topic>Biopolymers - analysis</topic><topic>Biopolymers - chemistry</topic><topic>Chromatography, Affinity</topic><topic>Chromatography, Affinity - methods</topic><topic>Competition assays</topic><topic>Drug Design</topic><topic>Life Sciences</topic><topic>Microchemistry</topic><topic>Microchemistry - methods</topic><topic>Molecular Weight</topic><topic>Pharmaceutical Preparations</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Selectivity</topic><topic>Subcellular Fractions</topic><topic>Subcellular Fractions - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guiffant, Damien</creatorcontrib><creatorcontrib>Tribouillard, Déborah</creatorcontrib><creatorcontrib>Gug, Fabienne</creatorcontrib><creatorcontrib>Galons, Hervé</creatorcontrib><creatorcontrib>Meijer, Laurent</creatorcontrib><creatorcontrib>Blondel, Marc</creatorcontrib><creatorcontrib>Bach, Stéphane</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Biotechnology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guiffant, Damien</au><au>Tribouillard, Déborah</au><au>Gug, Fabienne</au><au>Galons, Hervé</au><au>Meijer, Laurent</au><au>Blondel, Marc</au><au>Bach, Stéphane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</atitle><jtitle>Biotechnology journal</jtitle><addtitle>Biotechnology Journal</addtitle><date>2007-01</date><risdate>2007</risdate><volume>2</volume><issue>1</issue><spage>68</spage><epage>75</epage><pages>68-75</pages><issn>1860-6768</issn><eissn>1860-7314</eissn><abstract>Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>17225251</pmid><doi>10.1002/biot.200600223</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-7186-7483</orcidid><orcidid>https://orcid.org/0000-0003-3511-4916</orcidid><orcidid>https://orcid.org/0000-0003-4897-2995</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1860-6768 |
ispartof | Biotechnology journal, 2007-01, Vol.2 (1), p.68-75 |
issn | 1860-6768 1860-7314 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_00169462v1 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Affinity chromatography Biochemistry, Molecular Biology Biopolymers Biopolymers - analysis Biopolymers - chemistry Chromatography, Affinity Chromatography, Affinity - methods Competition assays Drug Design Life Sciences Microchemistry Microchemistry - methods Molecular Weight Pharmaceutical Preparations Pharmaceutical Preparations - chemistry Selectivity Subcellular Fractions Subcellular Fractions - chemistry |
title | Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20intracellular%20targets%20of%20small%20molecular%20weight%20chemical%20compounds%20using%20affinity%20chromatography&rft.jtitle=Biotechnology%20journal&rft.au=Guiffant,%20Damien&rft.date=2007-01&rft.volume=2&rft.issue=1&rft.spage=68&rft.epage=75&rft.pages=68-75&rft.issn=1860-6768&rft.eissn=1860-7314&rft_id=info:doi/10.1002/biot.200600223&rft_dat=%3Cproquest_hal_p%3E19772194%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19772194&rft_id=info:pmid/17225251&rfr_iscdi=true |